ALB Albemarle Corporation

Q2 2025 10-Q

Filed: Aug 4, 2025Period ending Jun 30, 2025

Health Care

Plastic Materials, Synth Resins & Nonvulcan ElastomersSEC EDGAR

Albemarle Corporation (ALB) 10-Q quarterly report for Q2 2025, filed with SEC EDGAR on Aug 4, 2025 for the fiscal period ending Jun 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q2 2025 10-Q

Risk Factors

• No material changes in risk factors from the most recent 10-K filing
• Continued exposure to market volatility impacting lithium demand and pricing

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$1.3B

Net Income

$23M

Gross Margin

14.8%

Operating Margin

3.6%

Net Margin

1.7%

Source: XBRL data from Albemarle Corporation Q2 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Albemarle Corporation Quarterly Reports

Q3 2025 10-Q

Q1 2025 10-Q

Get deeper insights on Albemarle Corporation

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.